Spruce Biosciences

A clinical stage biopharmaceutical company.

Spruce Biosciences is a clinical-stage biopharmaceutical focused on developing new treatments for rare endocrine disorders. Their mission is to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis (the “stress pathway”). They are committed to transforming the quality of life for patients who have been underserved by scientific innovation.